[4aS,9bR]-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole S-mandelate(CAS: 1059630-13-5)

This compound may be subject to various regulatory guidelines such as GHS classification for hazardous chemicals, REACH regulations for European manufacturers, and FDA/EPA requirements for use in pharmaceuticals and pesticides. Specific hazards and safety data sheets (SDS) should be consulted for detailed compliance information.

Alternative reagents like bromoacetic acid or brominated indoles can serve as substitutes depending on the specific synthesis requirements. However, the choice of alternative depends on the reaction conditions and desired product characteristics.

Research trends indicate growing interest in this compound for its potential applications in medicinal chemistry and natural product synthesis. Market analysis suggests increasing demand driven by its use in developing novel therapeutic agents.

Waste containing this compound should be collected in a sealed container, properly labeled, and disposed of according to local hazardous waste regulations. Incineration or professional waste disposal services are recommended to ensure environmental safety and compliance with regulations.